Skip to Main Content

Paper Details

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update.
J Clin Oncol
205
2017
Early-Stage Invasive Breast Cancer, HER2, HER2-positive or triple-negative breast cancer, MammaPrint, Women, breast cancer, breast-cancer, early-stage breast cancer, human epidermal growth factor receptor 2, human epidermal growth factor receptor 2 (HER2)-negative, node-negative breast cancer, patient, patients, women
Author NameAffiliation
Ian E KropDana-Farber Cancer Institute, American Society of Clinical Oncology, Institute Gustave Roussy, The University of Texas MD Anderson Cancer Center, Baylor University Medical Center, University of Utah and Intermountain Health Care, University of Washington Medical Center, Mayo Clinic College of Medicine, University of Michigan, Johns Hopkins University
Deborah CollyarDana-Farber Cancer Institute, American Society of Clinical Oncology, Institute Gustave Roussy, The University of Texas MD Anderson Cancer Center, Baylor University Medical Center, University of Utah and Intermountain Health Care, University of Washington Medical Center, Mayo Clinic College of Medicine, University of Michigan, Johns Hopkins University
Minetta C LiuDana-Farber Cancer Institute, American Society of Clinical Oncology, Institute Gustave Roussy, The University of Texas MD Anderson Cancer Center, Baylor University Medical Center, University of Utah and Intermountain Health Care, University of Washington Medical Center, Mayo Clinic College of Medicine, University of Michigan, Johns Hopkins University
Antonio C WolffDana-Farber Cancer Institute, American Society of Clinical Oncology, Institute Gustave Roussy, The University of Texas MD Anderson Cancer Center, Baylor University Medical Center, University of Utah and Intermountain Health Care, University of Washington Medical Center, Mayo Clinic College of Medicine, University of Michigan, Johns Hopkins University
Vered StearnsDana-Farber Cancer Institute, American Society of Clinical Oncology, Institute Gustave Roussy, The University of Texas MD Anderson Cancer Center, Baylor University Medical Center, University of Utah and Intermountain Health Care, University of Washington Medical Center, Mayo Clinic College of Medicine, University of Michigan, Johns Hopkins University
  • 1 - 5

Datasets

Release 1.2